Trial
NCT01969942
A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Louisville
Collaborators
—
Condition
Ewing Sarcoma
Intervention
allogeneic stem cell transplantation
Why stopped
No subjects meeting study inclusion were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-09